/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Clinical validated risk prediction model for development of heart failure after contemporary breast cancer treatment
Event: ESC Congress 2024
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Cardiomyopathies uncovered
When to use cardiovascular magnetic resonance in patients receiving chemotherapy?
Event: ESC Congress 2022
Topic: Cross-Modality and Multi-Modality Imaging Topics
Session: Meet the Experts: use of multimodality imaging to evaluate cardiotoxicity: when and how?
Physical training to prevent cardiotoxicity of cancer therapy.
Event: ESC Congress 2020
Topic: Cardio-Oncology
Session: Expert Advice - Cardiotoxicity of Cancer Therapy - An Ounce of Prevention...
Guidelines recommendations on the cardiovascular care of breast cancer patients.
Event: ESC Congress 2019
Topic: Cardio-Oncology
Session: Cardiovascular health in cancer patients and survivors
Effect of ethninicty on in-hospital outcomes of takotsubo cardiomyopathy, data from the national inpatient sample database.
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Risk prediction in heart failure outcome
Imaging techniques for detection of cardiac injury after cancer treatment.
Event: ESC Congress 2018
Topic: Cardio-Oncology
Session: Cardio-oncology: emerging concepts, challenges and clinical opportunities
Global longitudinal strain in the SAFE-HEaRT study (Cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function)
Event: ESC Congress 2018
Topic: Cardio-Oncology
Session: Cardio-oncology
MRI in clinical Cardio-Oncology
.
Event: CMR 2018 (the 5th joint EuroCMR/SCMR meeting)
Topic: Cardiac Magnetic Resonance (CMR)
Session: Lecture Session 7 - Imaging in Cardio-Oncology
